SOMATIC 2 MASTR Plus and QC Plex Product Release

SOMATIC 2 MASTR Plus and QC Plex Product Release

March 24, 2015

Multiplicom is pleased to introduce the SOMATIC 2 MASTR™ Plus, a research use only assay, for sequencing analysis of genes involved in pathways of solid tumors formation. The SOMATIC 2 MASTR Plus is provided as a ready to use assay in three multiplex PCR reactions for the identification of mutations in the complete coding regions of the EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN genes.

In addition, the QC Plex assay was released for quality assessment and integrity of FFPE-derived DNA samples. Together with the web-based DQC calculator (http://www.multiplicom.com/dqccalculator), the QC Plex ensures reliable amplification and reproducible results from SOMATIC 2 MASTR 2 plus when using DNA derived from solid tumors.

Improve DNA extraction from diverse soil environments

Improve DNA extraction from diverse soil environments

It is well known that the gut microbiota contributes to health and disease. Many studies have demonstrated that external factors such as diet, geographical location and host genetics are key contributors. However, the relative contribution of these factors in shaping the gut microbiota is unclear, likely due to large interindividual variation.

February 28, 2017 More +
BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us